Evofem Biosciences Inc
Change company Symbol lookup
Select an option...
EVFM Evofem Biosciences Inc
HLNE Hamilton Lane Inc
SAL Salisbury Bancorp Inc
MFON Mobivity Holdings Corp
XPEV Xpeng Inc
ENVX Enovix Corp
COGT Cogent Biosciences Inc
VONG Vanguard Russell 1000 Growth Index Fund ETF Shares
DPRO Draganfly Inc
BCIM abrdn Bloomberg Industrial Metals Strategy K-1 Free ETF
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. It is engaged in developing and commercializing products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). Its product, Phexxi vaginal gel, is a hormone-free, woman-controlled, on-demand prescription contraceptive gel for women. Its lead clinical program is evaluating Phexxi (using the investigational name EVO100) for the prevention of chlamydia and gonorrhea in women. EVO200 vaginal gel (EVO200), its investigational candidate for the reduction of recurrent bacterial vaginosis (BV), uses the same vaginal potential of hydrogen (pH) modulator platform as Phexxi. It also focuses on developing Multipurpose Prevention Technology (MPT) vaginal gel for indications, including the prevention of human immunodeficiency virus (HIV) in women through Orion Biotechnology Canada Ltd.

Closing Price
$0.383
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
18,951,799
0
  • Prev Close
    0.383
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    19.0M
  • Last (time)
    3:59p ET 08/16/22
  • Last (size)
    2.5K
  • 52-Wk Range
    0.275 - 14.61
    LowHigh
  • (08/31/21 - 06/16/22)
    39.27%
  • 185.6%
  • Market Cap
    31.6M
  • Shares Outstanding
    82.4M
  • -18.97
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • -1.6
  • 3.68
  • --

Latest News

August 10, 2022
8:23 pm ET
PR Newswire
10:40 am ET
PR Newswire
August 09, 2022
8:02 am ET
Accesswire
August 05, 2022
8:32 am ET
PR Newswire
August 04, 2022
4:01 pm ET
PR Newswire
August 03, 2022
8:24 am ET
PR Newswire
August 01, 2022
9:01 am ET
Newsfile
8:47 am ET
PR Newswire
July 29, 2022
8:32 am ET
PR Newswire
8:24 am ET
PR Newswire
July 28, 2022
8:47 am ET
PR Newswire
July 26, 2022
8:47 am ET
PR Newswire
July 25, 2022
8:47 am ET
PR Newswire
July 22, 2022
8:47 am ET
PR Newswire
July 21, 2022
8:46 am ET
PR Newswire
July 18, 2022
10:59 am ET
PR Newswire
July 12, 2022
9:35 am ET
PR Newswire
8:46 am ET
PR Newswire
July 08, 2022
8:30 am ET
PR Newswire
July 07, 2022
10:55 am ET
PR Newswire
July 06, 2022
10:45 am ET
PR Newswire
July 05, 2022
11:18 am ET
PR Newswire
July 01, 2022
10:50 am ET
PR Newswire
June 30, 2022
10:30 am ET
PR Newswire
8:46 am ET
PR Newswire
June 29, 2022
9:31 am ET
PR Newswire
June 28, 2022
1:13 pm ET
MarketWatch
8:30 am ET
PR Newswire
6:48 am ET
PR Newswire
June 27, 2022
2:13 pm ET
MarketWatch
2:12 pm ET
MarketWatch
8:30 am ET
PR Newswire
June 24, 2022
12:10 pm ET
MarketWatch
June 16, 2022
8:46 am ET
PR Newswire
June 07, 2022
8:16 am ET
Accesswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.